May 3, 2023
May 3, 2023 - GSK has announced that the US Food and Drug Administration (FDA) has approved Arexvy
(respiratory syncytial virus vaccine, adjuvanted)
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
News
May 2, 2023
May 02, 2023 - A new Cedars-Sinai AI tool may help predict the chance of adverse cardiac events and show how a
patient’s risk for these events can change over time.
May 1, 2023
May 01, 2023 - Avadel Pharmaceuticals plc, announced today that the U.S. Food & Drug Administration
(FDA) has granted final approval to Lumryz, an extended-release
April 28, 2023
April 28, 2023 – Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and
MedinCell (Euronext: MEDCL) announced that the U.S. Food and Drug
April 28, 2023
April 28, 2023 - Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck)
announced the U.S. Food and Drug Administration
April 27, 2023
April 27, 2023 - Teva Pharmaceuticals USA, has initiated a voluntary nationwide recall of specific lots of
various strengths of Fentanyl Buccal Tablets
April 26, 2023
April 26, 2023 - Seres Therapeutics, Inc. and Nestlé Health Science have announced the U.S. Food and
Drug Administration (FDA) approval of Vowst (fecal microbiota spores
April 26, 2023
April 26, 2023 - Akorn Operating Company LLC has filed Chapter 7 bankruptcy on February 23, 2023. In
connection with that filing, the company has ceased